News
LONDON (Reuters) -The World Health Organization plans to officially back the use of weight-loss drugs to treat obesity in ...
Eli Lilly's stock wobbled Thursday after a looming coverage hit was detailed for its blockbuster weight-loss drug Zepbound.
Hims & Hers launched a pharmacy-made weight-loss drug last year, taking advantage of an FDA rule allowing it to temporarily ...
Semaglutide, the active ingredient in popular drugs Ozempic and Wegovy, isn’t without its risks. A recent study has found ...
Kyle Richards and Mauricio Umansky's daughter, Sophia Umansky, posted a TikTok and revealed that she’s been taking Mounjaro for around four months. She explained that she believes the weight-loss drug ...
For most weight loss drug institutions, the idea of a class action lawsuit is frightening because it evokes nightmares of ...
Eli Lilly revenue surged in the latest quarter on steady sales of Mounjaro and other weight-loss treatments in its portfolio.
Ebn Sina Medical, a subsidiary of Aamal Company, and Danish healthcare major Novo Nordisk have launched the weight loss ...
Eli Lilly said sales of weight loss drug Zepbound and diabetes treatment Mounjaro soared in the first quarter.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback